ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,268Medicare Part D Prescriptions Filled, Including Refills

Rank: 257 out of 680

$418K Total Retail Price of All Prescriptions

Rank: 336 out of 680

608 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 608 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 7,512 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
TRIAMTERENE-HCTZ 550 480 1 52
PRAVASTATIN SODIUM 379 314 2 10
LISINOPRIL 376 319 3 5
SIMVASTATIN 329 283 4 3
HYDROCODONE-ACETAMINOPHEN 312 199 S3 5 4
METOPROLOL TARTRATE 304 259 6 12
OMEPRAZOLE 290 235 7 7
AMLODIPINE BESYLATE 274 227 8 1
LOSARTAN POTASSIUM 242 205 9 21
LEVOTHYROXINE SODIUM 230 217 10 2
FENOFIBRATE 184 151 11 66
GABAPENTIN 182 106 12 15
ATORVASTATIN CALCIUM 167 124 13 11
CITALOPRAM HBR 158 141 14 22
FUROSEMIDE 157 154 15 6
METFORMIN HCL ER 157 124 15 54
POTASSIUM CHLORIDE 139 120 17 14
GLIMEPIRIDE 128 91 18 29
AMITRIPTYLINE HCL 127 80 R 19 47
CARVEDILOL 123 113 20 23
ALPRAZOLAM 121 87 21 72
METOPROLOL SUCCINATE 113 107 22 13
TAMSULOSIN HCL 109 86 23 34
ATENOLOL 105 93 24 19
HYDROCHLOROTHIAZIDE 96 87 25 9
TRAMADOL HCL 90 90 26 18
METFORMIN HCL 80 64 27 8
TRAMADOL HCL-ACETAMINOPHEN 78 76 28 153
MELOXICAM 77 71 29 24
LOSARTAN-HYDROCHLOROTHIAZIDE 73 63 30 51
ALLOPURINOL 71 68 31 33
NEXIUM 71 56 31 16
ZOLPIDEM TARTRATE 70 47 33 17
SERTRALINE HCL 68 42 34 28
GLYBURIDE 62 58 R 35 85
CAPTOPRIL 59 59 36 257
FINASTERIDE 56 37 37 109
ADVAIR DISKUS 55 39 38 53
RAMIPRIL 54 51 39 69
ONGLYZA 52 33 40 136
ORPHENADRINE CITRATE 51 37 R 41 358
ALENDRONATE SODIUM 50 50 42 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.